Articles On Paragon Care (ASX:PGC)

4DMedical Ltd (ASX: 4DX) shares are having another positive session. At one stage today, the ASX healthcare stock was up as much as 7.5% to 78 cents. When its shares hit that level, it meant they were up 12% in the space of just two days....

Paragon Care Ltd (ASX: PGC) shares are taking off on Tuesday after returning from a trading halt. At the time of writing, the ASX small cap stock is up 27% to 26 cents. Why is this ASX small cap stock rocketing? Investors have been fightin...

Healius Ltd (ASX: HLS) shares are storming higher on Tuesday morning. In early trade, the beaten-up ASX 200 stock is up 14% to $1.28. Why is this ASX 200 stock jumping? Investors have been buying the healthcare company's shares this mornin...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ — AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited (ASX: PGC), a premier provider of healthcare...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

  Stocks settled lower on Thursday as investors remain cautious ahead of key jobs data on Friday that could determine the next move for interest rates. The Dow Jones Industrial Average closed down 10 points, or 0.03 per cent. The S&P 50...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

  Stocks fell Friday as investors wrapped up a volatile week ahead of the Federal Reserve’s policy meeting. The Dow Jones Industrial Average slid 288.87 points, or by 0.83 per cent, to 34,618.24. At its lows, the index completely wiped out...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AIM)) - Ai-Media Technologies ((AMI)) - Aurelia Metals ((BXB)) - Brambles ((C79)) - Chrysos ((CYG)) - Coventry Group ((DDR)) - Dicker Data ((EML)) - E...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market. by Tim Boreham ASX Code: ((IDT)) Share price: 6.7 cents Shares on issue: 351,337,149 Market cap: $23.5m Chief ex...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

World Overnight SPI Overnight 7360.00 – 39.00 – 0.53% S&P ASX 200 7450.70 + 40.30 0.54% S&P500 4576.73 – 12.23 – 0.27% Nasdaq Comp 14283.91 – 62.11 – 0.43% DJIA 35630.68 + 71.15 0.20% S&P500 VIX 13.93 + 0.30 2.20%...

World Overnight SPI Overnight 7383.00 + 25.00 0.34% S&P ASX 200 7410.40 + 6.80 0.09% S&P500 4588.96 + 6.73 0.15% Nasdaq Comp 14346.02 + 29.37 0.21% DJIA 35559.53 + 100.24 0.28% S&P500 VIX 13.63 + 0.30 2.25% US 10...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Japanese beer giant Kirin becomes substantial shareholder of Blackmores after $1.2 takeover bid State Street Corporation becomes substantial shareholder of Gold Road Resources as gold prices rallies State Street Corporation sells out of Sa...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

A handful of ASX biotechs are entering their crucial stages of development Promising outlooks for PharmAxis, Botanix Pharma, and Paragon Care   Pharmaxis could surge if FDA application successful Broker Taylor Collison sees an Outperform...

ShareCafeUS regional banks slammed as SVB saga continues                    The Dow Jones Industrial Average dropped on Monday as a plan to backstop all the depositors in failed Silicon Valley Bank, along with other extraordinary meas...

Some of the smaller ASX dividend shares could be contenders for good dividends and growth in the future. I think one name to consider is Paragon Care Ltd (ASX: PGC). After going through a difficult period over the last few years, the ASX h...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

ShareCafeStocks rise as bond yields fall: All eyes on RBA rate decision today                    Stocks rallied Monday for the start to the new month and quarter, as Treasury yields eased from levels not seen in roughly a decade. The...

ShareCafeKey week for US economic data as indexes produce strong weekly gains                    US equities were higher in Friday trading, finishing just off best levels. Each of the major averages were up more than 2.5 per cent for...

ShareCafeLunch Report: 25 August, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.68 per cent or 47.40 points higher at 7045.50. The SPI futures are pointing to a rise of 56 points Best and worst performers The best-performing secto...

ShareCafeStocks of the Hour: 25 August, 2022                    Bulletin Resources (ASX:BNR) today provided an update on its Ravensthorpe Lithium Project. The project is located only 12km southwest, along the strike of Allkem Limited’...

25 Aug 2022 - A snapshot of the stocks on the move featuring Bulletin Resources (ASX:BNR), Paragon Care (ASX:PGC) and Magnis Energy Technologies (ASX:MNS).

The ASX 200 will open higher on Thursday The gathering of world central bankers in Wyoming begins today US time European gas prices rise again ahead of pipeline maintenance work Local shares are set to open higher today. At 8am AEST, the...

ShareCafeEvening Report: 26 July, 2022 by Paul Sanger   The S&P/ASX 200 closed marginally higher on Tuesday in a reasonably quiet trading session as investors prepare themselves for the busiest week of corporate earnings in the US and W...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Highlights 5 ASX-listed companies Adairs Limited (ASX:ADH), Apiam Animal Health Ltd (ASX:AHX), K&S Corporation Limited (ASX:KSC), NRW Holdings Limited (NWH), and Paragon Care Ltd (ASX:PGC), turned ex-dividend today.    The share...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Careteq (CTQ) fell flat on its ASX debut today, with shares trading down 25 per cent on the IPO issue price of 20cents – shares traded at 16 cents at the market close Through its IPO, Careteq issued 30 million shares, raising $6 million, i...

Highlights Careteq is slated to list on the ASX on Monday (10/01/22) at 11AM. Funds raised from the IPO will be used to fast-track growth of its Assistive Living Technology solution globally to disrupt the large aged and disability car...